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Electrophysiological conversion of chloride-dependent synapses from inhibitory to excitatory function, as a result of aberrant
neuronal chloride homeostasis, is a known mechanism for the genesis of neuropathic pain. This paper examines theoretically
how this type of synaptic conversion can disrupt circuit logic in spinal nociceptive circuits. First, a mathematical scaling factor
is developed to represent local aberration in chloride electrochemical driving potential. Using this mathematical scaling factor,
electrophysiological symbols are developed to represent the magnitude of synaptic conversion within nociceptive circuits. When
inserted into a nociceptive circuit diagram, these symbols assist in understanding the generation of neuropathic pain associated
with the collapse of transmembrane chloride gradients. A more generalized scaling factor is also derived to represent the interplay
of chloride and bicarbonate driving potentials on the function of GABAergic and glycinergic synapses. These mathematical and
symbolicrepresentationsofsynapticconversionhelpillustratethecriticalrolethataniondrivingpotentialsplayinthetransduction
of pain. Using these representations, we discuss ramiﬁcations of glial-mediated synaptic conversion in the genesis, and treatment,
of neuropathic pain.
1.Introduction
Neuropathic pain involves multiple interlocking molecular
and cellular pathologies [1, 2]. One of these pathologies
is the alteration of transmembrane chloride gradients in
nociceptive neurons, induced by chemical signals released by
neighboring activated glia [3–5]. It is now well established
that aberrant transmembrane chloride gradients in noci-
ceptive neurons can result in a pathological functioning of
antinociceptive chloride-dependent synapses [6]( F i g u r e1).
The transmembrane chloride gradient within a postsynaptic
nociceptiveneuronis thereforeakeyvariablethat determines
the excitability of tetrapartite synapses,t h a ti s ,n e u r o n a l
synapses that are modulated by the actions of gliotransmit-
ters released by neighboring astrocytes and microglia [7]
(Figure 2).
Chloride-dependent synapses (e.g., GABAergic and gly-
cinergic) play critical roles in the production of inhibitory
tone in both the central (CNS) and peripheral mammalian
nervous system (PNS) [6, 8]. As primary nociceptive af-
ferents become inﬂamed, the sodium-potassium-chloride
cotransporter, NKCC1, is thought to be upregulated [9].
It has been proposed that NKCC1 upregulation leads to
excessive chloride accumulating in the terminals of primary
aﬀerents,which inturnleadstoexcessivepresynapticaﬀerent
depolarization (PAD) at these locations [9, 10]. Instead of
producing inhibition at the terminals of primary nociceptive
aﬀerents, action potentials may be initiated by the excessive
PAD, resulting in antidromic ﬁring, a neuronal behavior
known as a dorsal root reﬂex [8–11].
Dorsal root reﬂexes can cause CGRP (calcitonin gene-
related peptide) and substance P to be released from C ﬁbers
in peripheral tissues. This pathological process is considered
to be a potent mechanism for the generation of visceral
hypersensitivity and dermal hyperalgesia [8–12]. In addition
to antidromic ﬁring, sites of excessive PAD in primary2 Pain Research and Treatment
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Figure 1:Ohm’slawfora chloridecurrent ina postsynapticmembrane.Totalsynapticcurrent forchloride,ICl,isthesummationofchloride
currents ﬂowing through individual chloride channels. The total driving potential Δ for chloride (see (1)) is given by [Vm − ECl]. Chloride
channelopathies (i.e., mutation of chloride channels) alter the ionic conductance of individual chloride channels, gCl,t h u sp r o d u c i n g
pathological chloride currents. Pathological changes in the Nernst potential for chloride (i.e., chloride-opathies) can also produce aberrant
chloride currents. Aberrations in ECl can result from pathological changes in either intracellular or extracellular chloride concentration.
aﬀerents can also ignite volleys of actions potentials into the
dorsal horn, contributing to the generation of neuropathic
pain [10, 11].
Excessive PAD at the terminals of primary nociceptive
aﬀerents is not the only mechanism by which aberrant
chloridehomeostasiswithinnociceptivecircuitscangenerate
neuropathic pain. A separate mechanism involves a loss
of chloride-dependent inhibitory tone within the central
nervous system (CNS). This occurs when intracellular chlo-
ride concentration within nociceptive projection neurons
becomes elevated above normal homeostatic levels [6].
In rodents, terminals of injured peripheral neurons
are known to release ATP and cytokines (e.g., monocyte
chemotactic protein 1 (MCP-1) and fractalkine) that acti-
vate microglia within the spinal cord [13]. As part of
their neuroprotective response, activated spinal microglia
can release brain-derived neurotrophic factor (BDNF) [3].
BDNF produces a downregulation of the outward chloride
cotransporter, KCC2, resulting in an increase of intracellular
chloride in CNS neurons [3, 14]. When the transmembrane
Nernstpotential forchlorideECl becomesmore positive than
theresting potentialVm fortheneuron(i.e.,whenECl > Vm),
the electrochemical driving potential for chloride current
becomes inverted. As a result, chloride-dependent inhibitory
synapses undergo an electrophysiological conversion to
become excitatory synapses (Figure 3). This synaptic behav-
ior is known to occur in lamina I nociceptive projection
neurons, contributing to tactile allodynia (ampliﬁed pain in
response to a nonnoxious stimulus) [3].
For nearly 20 years, the term channelopathy has been
used to describe neurological and muscular pathologies
arising from the molecular mutation of ion channels [15,
16]. A number of inherited neurological disorders, such as
epilepsy, ataxia, and sensory pathologies have been linked
to the altered ionic conductances of mutated ion channels
[17, 18]. Channelopathies produce aberrant transmembrane
ion currents, which consequently induce pathological ﬁring
patterns in aﬀected neural circuits.
Pathologies in transmembrane ion currents can also
occur when electrochemical driving potentials for speciﬁc
ions become shifted outside of their normal range of
function. Anumber ofphysiological stressors (e.g.,ischemia,
cellular injury, temperature shifts, toxins, pharmacological
agents, endocrine signals), as well as tissue inﬂammatory
processes, can produce pathological changes in transmem-
brane ion gradients and neuronal excitability. Transmem-
brane chloride gradients, in particular, play a key role in the
genesis of inhibitory tone in the mature vertebrate nervous
system [19, 20]. For this reason, aberrant transmembrane
chloride gradients in postsynaptic neurons can potentially
produce pathological eﬀects in each function of the nervous
system, including the sense of nociception [19].
In this paper, we utilize the term chloride-opathy to
describe neuropathologies that arise from aberrant chloride
homeostasis. In the following section, we develop a math-
ematical scaling factor to quantify the eﬀects of chloride-
opathies on the function of chloride-dependent GABAergic
and glycinergic synapses. We then use this scaling factor toPain Research and Treatment 3
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Figure 2: A “tetrapartite” synapse in the CNS: A GABAergic
synapse modulated by reciprocal signaling and homeostatic inter-
actions with neighboring astrocytes and microglia [7]. GABAergic
synapses employ ionotropic (GABA-A receptors) and metabotropic
(GABA-B) receptors to evoke postsynaptic potentials [1]. The
ionotropic GABA-A receptor is a ligand-gated chloride channel.
The metabotropic GABA-B receptor activates a hyperpolarizing
potassium conductance through a G-protein-mediated pathway
[1]. As part of their neuroprotective response, activated microglia
release brain-derived neurotropic factor (BDNF) in response to
neuronal or vascular injury. BDNF triggers a transcriptional
downregulation of KCC2 (potassium-chloride cotransporter 2),
leadingto reduced chlorideextrusion fromthecell [3].Pathological
accumulation of intracellular chloride can be reduced by blocking
the inward sodium-potassium-chloride cotransporter (NKCC1)
with bumetanide [6]. Diminished functioning of the GABA-A
receptor, because of a collapsed chloride gradient, could be
compensatedforapplyingbaclofen,aGABA-B agonist[22].As pain
therapeutics, bumetanide andbaclofen,oﬀer diﬀerent physiological
approaches to deal with the chloride-opathy in the postsynaptic
neuronal cell.
portray how spinal nociceptive circuitsbecome perturbed by
chloride-opathies.
2. Methods and Modeling
2.1. Electrodynamics of Chloride-Dependent Synapses. To
model the altered behavior of a synapse with a chloride-
opathy, it is particularly useful to reference the magnitude
and sign of the altered chloride current to the normal
chloride current. To accomplish this, one must ﬁrst identify
altered components to the chloride driving potential, and
reference these changes to the norm-averaged components
of the chloride driving potential.
Total chloride current ICl through a synaptic membrane
is given by:

iCl = ICl = GCl[Vm − ECl] = GClΔ,( 1 )
−1
0
1
2
CF
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Δo −Δμ
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Figure 3: Electrophysiological conversion of chloride-dependent
inhibitory synapses in the CNS. Neuropathologies arising from
aberrant chloride homeostasis (i.e., chloride-opathies) can be
mapped onto a graph of the Conversion Factor, CF,v e r s u sΔμ.
CF is a scaling factor for synaptic response. Aberrant chloride
current is scaled to the synaptic chloride current under normal
conditions(i.e.,Δμ = 0).Thegraphillustratesthespecialcaseof (8)
where the resting membrane potential is unchanged in the cell with
altered chloride driving potential (i.e., ΔV = 0). Downregulation of
Potassium Chloride Cotransporter (KCC2) leads to an increase in
intracellular chloride. Hyperpolarizing GABAergic and glycinergic
synapses become depolarizing synapses when E
∗
Cl becomes more
positive than Vm.
where iCl is the unitary current of a single chloride channel,
and GCl is the total chloride conductanceofthe synapse [21].
The quantity [Vm −ECl]i st h ed i ﬀerence between the resting
membrane potential and the Nernst potential for chloride.
In this paper, we hereafter refer to this diﬀerence in total
electrochemical driving potential for chloride as the chloride
driving potential. This total chloride driving potential is
represented by the symbol, Δ.
Inward chloride ﬂux across the cell membrane corre-
sponds to an inhibitory, hyperpolarizing current. As intra-
cellular chloride is increased in the postsynaptic cell, ECl >
Vm, the driving potential becomes inverted. The synaptic
response becomes converted to an excitatory response. Here-
after, this process will be referred to as synaptic conversion
(Figure 3).
Synapticconversionisdirectlytiedtothetransmembrane
driving potential for the chloride ion. In this section, inde-
pendent changes in the contributions of chemical potential
and electrical potential to the total driving potential for
chloride are ﬁrst represented mathematically. Once such
changes in chloride-dependent tone have been quantiﬁed,
thesechangescanbeplacedwithinthecontextofthesynaptic
tone of spinal nociceptive circuits.
To avoid the complexities of solving time-dependent dif-
ferential equations, synaptic currents are often represented as
steady-state conditions [21].Synapticcurrents are, therefore,
often discussed using a steady-state version of Ohm’s law.
For a chloride-dependent synapse, with a given chloride
conductanceGCl, membrane potential (Vm)and the chloride4 Pain Research and Treatment
Nernst potential (ECl) are the two variables that will alter a
chloride current from its normal value. These relationships
can be seen in the following steady-state Ohmic relation:
I∗
Cl = GCl

Vrest − Eo
Cl

+ (Vm − Vrest) −

E∗
Cl − Eo
Cl

.
(2)
Equation (2) can be rewritten to emphasize changes in the
chloride driving potential:
I∗
Cl = GCl

Δo +ΔV −Δμ

= GClΔ∗
Cl,( 3 )
where GCl is the chloride conductance, and Δ
∗
Cl is the altered
electrochemical driving potential for chloride ﬂux across the
cell membrane, and
Δo = Vo
rest − Eo
Cl
= net chloride driving potential
at normal conditions

denoted by o

(4)
ΔV = Vm −Vrest
= diﬀerence in membrane potential
and resting membrane potential,
= perturbation in membrane potential
(5)
Δμ = E
∗
Cl − Eo
Cl
= diﬀerence in chloride Nernst potential between
perturbed

denoted by ∗

and normal cellular states
= perturbation in chloride chemical potential.
(6)
Note.Thesymbol∇wasused byCoull etal. [3]t od e n o t et h e
shift in the reversal potential for anion currents in lamina
I projection neurons. In this paper, the term Δμ is used
to emphasize deviations in the chloride chemical potential
(denoted by μ) from resting conditions.
This theoretical approach changes the representation
of postsynaptic chloride current from being a function of
membrane potential and chloride Nernst potential, that is,
ICl(Vm,ECl), into a function that is dependent on deviations
from a normal resting chloride driving potential, Δo.T h e
postsynaptic chloride current, ICl(ΔV,Δμ,Δo), becomes a
function of the change in membrane potential, as well as
the change in chloride chemical potential, from the normal
resting chloride driving potential.
There are two major advantages of representing ICl in
this manner. Firstly, changes in the chloride driving potential
are explicitly separated into two deﬁned variables: changes in
membrane potential (ΔV) versus changes in chloride chem-
ical potential (Δμ). Secondly, altered response in an aberrant
chloride-dependent synapse can be quantitatively compared
to the “normal” chloride driving potential, Δo. Separating
changes in membrane potential, ΔV, from changes in chlo-
ridechemicalpotential,Δμ,providesananalyticalframework
to understand the process of synaptic conversion.
In quantifying the magnitude of synaptic conversion, it
is important to emphasize that the unitary conductance, gCl,
of an individual chloride ion channel is not altered between
the two cellular states (i.e., normal versus chloride-opathy).
An altered chloride driving potential does not change the
transmembrane potential across a cell membrane. For this
reason, the chloride channel will not change its three-
dimensional structure, or its conductance, in response to
a change in the transmembrane chloride gradient. Thus,
the magnitude of individual chloride channel conductance,
which remains unchanged, can be represented by
go
Cl = g
∗
Cl. (7)
With no change in ionic conductance, aberrations in
chloride current are linkedsolely to changes in chloride driv-
ing potential, Δ. One can directly compare aberrant trans-
membrane chloride current, I
∗
Cl, to normal chloride current,
ICl, in a given chloride-dependent synapse. To accomplish
this, it is useful to deﬁne a scaling factor, hereafter referred
to as the synaptic Conversion Factor:
CF =
I
∗
Cl
Io
Cl
=
Δo + ΔV − Δμ
Δo =
Δ∗
Δo . (8)
CF is a unit-less variable, which references an aberrant
chloride driving potential to the chloride driving potential
in the normal state. The Conversion Factor can be viewed
as a scaling factor for synaptic response. CF can be used
in combination with other unit-less variables, such as the
electrotonic length L = l/λ,o re l e c t r o t o n i ct i m eT = t/τ,
which are each scaled to inherent physical properties of the
neuronal membrane (i.e., l: length of neuronal cable; λ:
electrotonic length constant; t:r e a lt i m e ;τ:e l e c t r o t o n i ct i m e
constant of neuronal membrane).
In the case of a steady-state postsynaptic current,
I∗
Cl =
	
Δo + ΔV − Δμ
Δo


· Io
Cl = CF ·Io
Cl. (9)
Although chloride-opathies change the magnitude and/
or direction of chloride-dependent synaptic currents, the
passive electrotonic cable properties of aﬀected neurons
would remain unaltered. For example, if this aberrant
postsynaptic current occurred at the terminus of a neuronal
dendrite, the aberrant postsynaptic potential V∗
psp occurring
at the neuronal soma would be approximated by:
V∗
psp =

CFIo
Cl

rm
AN

LN
tanhLN

= I∗
Cl · RN, (10)
where rm is the speciﬁc resistance of the neuronal cell
membrane, AN is the area of neuron, LN is the combined
electrotonic length of the dendrite and soma, and RN is
the input resistance of the neuron (modiﬁed from (5.16) in
[23]). Equation (10) illustrates that electrotonic properties
o ft h en e u r o n a lm e m b r a n eo u t s i d eo ft h es y n a p s er e m a i n e d
unchanged by the change in chloride driving potential at the
chloride-dependent synapse. Note that the neuronal input
resistance, RN, is the same whether current in the chloride-
dependent synapse is driven by a normal driving potential,
Δo, or by an altered driving potential, Δ∗.Pain Research and Treatment 5
In the following section of this paper, we develop a set of
symbolstorepresenttheeﬀectsofchloride-opathiesonnoci-
ceptive circuits. These symbols allow logic representations
for synaptic response to be illustrated within the context of
spinal nociceptive circuits.
2.2. Symbolic Representations of Synaptic Conversion. The
reversal potential, Erev, for a given ion channel is a funda-
mental concept in electrophysiology. Ionic current through
the ion channel reverses direction when the driving potential
(i.e., Vm − Erev) passes through the reversal potential for
the ionic channel (Figure 3). A sustained shift in synaptic
driving potential can thus reverse current ﬂow through the
ion channels of a synapse, and thus fundamentally change
the functional response of the synapse (i.e., the magnitude
and/or sign of the postsynaptic current). Previous authors
have described this change as an inversion of the synaptic
response [3, 5, 24]. Here, we employ the general term
synaptic conversion to describe a continuum of aberrant
synaptic response, which arises when the resting driving
potential for the chloride ion deviates from time-averaged
normalcy.
Changes in membrane potential are often coincident
withtheopeningofachloride-dependentsynapse (3). In this
case, ICl is determined by the local chloride driving potential,
which is a combination of the local membrane potential and
the local chloride chemical potential.
In the following discussion, we deal with the special case
of ΔV = 0, to focus analysis on eﬀects of chloride-opathies
on the function of spinal reﬂex circuits. In this condition,
changes in intracellular chloride concentration aﬀect the
Nernst potential for chloride, ECl, but do not directly
change the resting membrane potential of the neuron, Vm.
Thus, Δμ is the independent variable in the ionic transport
equation that describes aberrant chloride current. This
allows the altered response of chloride-dependent synapses
to be viewed as being altered by changes in Δμ,t h a ti s ,
the mathematical term that quantiﬁes the magnitude of the
chloride-opathy in the aﬀected synapse. The term synaptic
conversionisappropriatetousewhenthechloride-dependent
synapse loses inhibitory strength and becomes progressively
changed to an excitatory response asthe chloride-opathy, Δμ,
increases in magnitude.
To represent the concept of synaptic conversion in
neuronal circuit diagrams, it is necessary to develop speciﬁc
symbols that can be used to quickly identify an aberrant
chloride-dependent synapse. These symbols can be incorpo-
rated into neuronal circuit diagrams to illustrate functional
changes in synaptic behavior, as well as to visualize neural
circuit behavior.
Traditionally, an open triangle is often used to denote
an excitatory synapse [25]. An open circle is used to denote
thecell body ofa pre-synaptic excitatory neuron. Conversely,
a dark circle and dark triangle are used to represent the
cell body and synaptic terminal of an inhibitory neuron. To
denote a chloride-opathy in a postsynaptic CNS neuron, we
shade the cell body yellow (Figure 4). To denote synaptic
conversion in a chloride-dependent synapse, we utilize
an open triangle with an associated asterisk. An asterisk
(a)
Cl−
CF = 1
(b)
∗
Cl−
CF =− 1
(c)
Figure 4: Symbolic representations for normal and aberrant
chloride-dependent synapses. Excitatory and inhibitory synapses
are denoted based upon the postsynaptic response. The Conversion
Factor (CF = I
∗
Cl/Io
Cl)( s e e( 8)) and the chloride ﬂux are shown for
chloride-dependent synapses with normal and aberrant (denoted
with asterisks) postsynaptic responses. (a) Excitatory neuron
with excitatory postsynaptic response. (b) Inhibitory neuron with
inhibitory postsynaptic response. (c) Inhibitory neuron with a
converted chloride-dependent synapse. The aberrant excitatory
response is denoted with an asterisk and an open triangle. Elevated
chloride in the postsynaptic cell is denoted with yellow.
draws attention to a speciﬁc synapse that is aﬀected by a
chloride-opathy in a neural circuit. In these representations,
GABAergic and glycinergic neurons retain dark cell bodies.
The terminals of these neurons, however, have an open
triangle with an asterisk, denoting an excitatory postsynaptic
response. In situations where it is advantageous to express
the magnitude of synaptic conversion, the value of the
Conversion Factor, CF, can be placed next to the aﬀected
synapse.
3.Resultsand Discussion
3.1. Synaptic Conversion and Allodynia. Using the symbols
deﬁned in the previous section, we graphically represent a
mechanism underlying the onset ofallodynia (Figure5). Pri-
mary Aβ aﬀerents activate GABAergic interneurons within
the upper laminae of the dorsal horn [3]. These GABAergic
interneurons synapse onto the same lamina I projection
neuronsthatareinnervatedbyAβ aﬀerents(seecircuitmodel
in[25]).Withsynaptic conversion,GABAergicsynapses onto
lamina I projection neurons change from being inhibitory
synapses to excitatory synapses [3, 6].
The ramiﬁcations of the loss of chloride-dependent
inhibitory tone in several spinal circuits are profound.
Stimulation of Aβ ﬁbers normally leads to touch-evoked
analgesia. This occurs through the activation of GABAergic
interneurons, which normally provide inhibitory tone to
lamina I nociceptive projection neurons. After synaptic
conversion, an inverted physiological response occurs at6 Pain Research and Treatment
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Figure 5: Chloride-opathies and allodynia. Symbolic representation of the concepts and results of Coull et al. [3]. (a) A normalnociceptive
neuronal circuit in the mammalian dorsal horn. A myelinated Aβ ﬁber synapses directly onto a lamina I projection neuron (PN), which
projects to the thalamus.The Aβ ﬁber alsosynapses onto a GABAergic inhibitory interneuron, which suppresses PN activity via feedforward
inhibition [25]. (b) Electrodynamics of chloride-dependent synapses. After neuronal or vascular injury, microglia in the dorsal horn release
BDNF, resulting in a downregulation of KCC2 (Figure 2). This causes an increase in intracellular chloride (Figure 3), and a shift in the
normal chloride Nernst potential to a more positive value, E
∗
Cl. A shift in resting membrane potential may also occur, to a new resting level,
V∗
m.W h e nE
∗
Cl > V∗
m synaptic conversion occurs in the chloride-dependent synapse, resulting in the generation of excitatory postsynaptic
potentials (EPSPs), instead of inhibitory postsynaptic potentials (IPSPs). (c) A symbolic representation of tactile allodynia. When the PN
develops high intracellular chloride (yellow), its chloride-dependent synapses undergo synaptic conversion. Activation of the GABAergic
interneuron results in the aberrant excitation of the PN, resulting in tactile allodynia. Synaptic conversion has produced a pathology in the
logic of the nociceptive circuit. Because of the chloride-opathy in the PN, the nociceptive circuit with feedforward inhibition (a) has been
converted into a nociceptive circuit that manifests aberrant feedforward facilitation.
this synapse; stimulation of Aβ ﬁbers leads to touch-evoked
allodynia [3].
Loss of chloride-dependent inhibitory tone can pro-
foundly alter the function of pain circuits. Although the
continuity of the nociceptive circuits is intact, the logic
encoded in the neural circuit can become fundamentally
disrupted. For instance, synaptic conversion in lamina I
projection neurons [3] leads to a disruption of circuit logic
in the dorsal horn by creating feedforward facilitation of
nociception, instead of feedforward inhibition—the normal
pain gating function of the circuit (Figure 5).
3.2. Psycho-PhysiologicPain Ampliﬁcation. T h ee x p e ri e n c eo f
neuropathic pain can be highly variable, changing with the
mental focus and emotional state of the aﬀected individual
[26]. This is because supraspinal and spinal circuits can
interact to attenuate, or potentiate, the experience of painful
stimuli [26]. In the context of centralized neuropathic
pain, how do chloride-opathies at the spinal level inﬂuence
the transduction of antinociception? This question can
potentially be addressed by considering the transduction
of pain in patients with Complex Regional Pain Syndrome
(CRPS).
CRPS is a neuropathic pain disorder characterized by
both peripheral and central neuroinﬂammation, which is
often triggered by peripheral nerve injuries [29–31]. Indi-
viduals with CRPS frequently have tactile allodynia [32]. A
recent postmortem analysis of a patient with long-standing
CRPS revealed strong microglial and astroglial activation
in the segments of the spinal cord that are ipsilateral and
somatotopic to the aﬀected limb [31]. Animal models with
neuropathic pain also show both astroglial and microglial
activation in spinal segments that are ipsilateral and somato-
topic to peripheral nerve injuries [13, 33, 34]. Thus, individ-
uals with CRPS may represent a cohort of neuropathic pain
patients, inwhich bothspinal neuroinﬂammation and spinal
chloride-opathies are present.Pain Research and Treatment 7
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Figure 6: Psychophysiologic pain can potentially arise when
descending GABAergic neurons from supraspinal sites drive spinal
nociceptive circuits that have been altered by synaptic conversion.
The anterior cingulate cortex (ACC) becomes activated during
strong emotional states (e.g., anger or fear), as well as during
psychological conﬂict [26]. The ACC also regulates the experience
of pain, as well as the anticipation of pain. The ACC drives the
periaqueductal grey (PAG) region of the midbrain [27], which
i nt u r nd r i v e st h en u c l e u sr a p h em a g n u s( N R M ) ,a sw e l la st h e
rostralventrolateralmedulla(RVM).GABAergic ﬁbersthatdescend
from the NRM and RVM innervate lamina I projection neurons
in the dorsal horn of the spinal cord. When the projection neuron
has abnormally high intracellular chloride (i.e., a chloride-opathy),
the descending GABAergic drive becomes pro-nociceptive [24].
Normally, this drive is antinociceptive. Thus, a major pain coping
mechanism, originating at supraspinal levels, is compromised by
neuroinﬂammationand chloride-opathies at the spinal level.
Psychoactive pain is prevalent in individuals with Com-
plex Regional Pain Syndrome (CRPS). For a number of
individuals with CRPS, the experience of strong emotions
[26], and even the ideation of movement of an aﬀected
limb, can initiate pain [35]. Thus, the intensity of pain in
individuals with CRPS, as well its dependence on mental
activities, is far beyond normal experience [26, 36].
Prescott et al. [24] have emphasized that descending
GABAergic ﬁbers from supraspinal centers can increase
excitability of spinal projection neurons, if the projection
neuronshavecollapsed chloridegradients.Amajorantinoci-
ceptive pathway has become altered into a pro-nociceptive
pathway, as a result of microglial activity in the vicinity
of the projection neuron. Prescott et al. [24]p r e d i c tt h a t
pain will be generated from normal descending inhibitory
GABAergic ﬁbers from the midbrain or brainstem, as they
interact with nociceptive projection neurons, which have
undergone synaptic conversion of their GABAergic and
glycinergic chloride-dependent synapses.
The anterior cingulatecortex (ACC)is known to regulate
distressing aspects of pain, as well as modulate anticipatory
responses and mental attention towards pain [26]. In
Bumetanide
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1
0.1
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ﬂuxes
Reduced chloride ﬂux,
loss of inhibitory tone
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μ
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HCO3
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HCO3
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μ
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Figure 7: Pharmacological management of chloride-opathies.
Canion
F dependence on Cl and HCO3 driving potentials (see (12)).
In the above hypothetical case, the Io
Cl/Io
HCO3ratio for normal anion
currents through ligand-gated chloride channel (a GABA-A or a
glycine receptor) is assumed to be 10:1. No change in resting
membrane potential occurs (i.e., ΔV = 0) in this example, as anion
driving potentialsdeviatefromtheirnorm-averagedvalues(Δ
μ
Cl and
Δ
μ
HCO3).AtCanion
F = 0,theinwardﬂuxofchlorideiscounterbalanced
by an equal and opposite ﬂux of HCO3. Chloride-dependent
inhibitory tone in the aﬀected synapse has been lost. Bumetanide,
an inhibitor of NKCC1 (sodium-potassium-chloride cotransporter
1), reduces the transport of chloride into the postsynaptic neuron
(Figure 2). With a reduction of intracellular chloride, Canion
F moves
back towards a normal value of 1. A novel approach to restoring
a positive value of Canion
F is to reduce intracellular bicarbonate
(HCO3) concentration with the carbonic anhydrase inhibitor,
acetazolamide[28].Thisoccurswhilethecollapsedchloridedriving
potential, Δ
μ
Cl, remains unchanged. Bumetanide and acetazolamide
have antiallodynic actions in animal models of neuropathic pain
[6].
rodents, it has been hypothesized that the ACC produces
short-term antinociception by stimulating the PAG [27],
which in turn activates inhibitory descending tone to dorsal
horn nociceptive neurons [37–39]. Extrapolating this hypo-
thetical pathway to humans, mental activity that activates
t h eA C Cw o u l db ee x p e c t e dt op r o d u c ea n t i n o c i c e p t i o nb y
driving the PAG [24, 27] ,w h i c hi nt u r nw o u l dd r i v et h e
ﬁring of GABAergicneurons from the nucleusraphemagnus
(NRM) and rostral ventrolateral medulla (RVM) (Figure 6)
[27, 37, 38].
The above hypothetical transduction pathway would be
alteredgreatlyinindividualswithspinal neuroinﬂammation.
With synaptic conversion occurring in spinal projection
neurons, normal inhibitory tone produced by descending
GABAergic neurons from the NRM and RVM would be
changed into excitatory tone [24]. An inverted physiological
response would be expected to occur as a consequence. Pain8 Pain Research and Treatment
would be enhanced by mental states (stress, conﬂict) that
activate the ACC (Figure 6). In contrast, mental distractions
oftheindividual wouldbeexpected toattenuatetheintensity
of neuropathic pain, by reducing the activity of the ACC and
the PAG.
This proposed etiology may help explain observations by
Dr. Silas Weir Mitchell [40] during the American Civil War,
in soldiers with CRPS. Mitchell described a strong linkage
between aﬀective state and pain in certain CRPS patients
“...every strong moral emotion made him worse—anger or
disappointment expressing themselves cruelly in the aching
limb.”
From a diagnostic perspective, this type of pain could
easily be interpreted as psychogenic, because the observed
pain is associated with speciﬁc types of mental activity.
However, the term psychogenic pain has traditionally meant
pain originating in the mind [41]. For the conditions
diagramed in Figure 6, the term “psycho-physiologic pain”
is a more apt descriptor of the pain-generating pathway,
whichinvolvessupraspinalactivationofadisinhibited,spinal
nociceptiveneuron.Fromthisperspective,theneuralcircuits
with synaptic conversion, shown in Figures 5 and 6,p r o v i d e
a common mechanistic linkage for two types of evoked pain
(i.e., tactile allodynia and emotion-linked pain) experienced
by CRPS patients.
3.3. Transmembrane Bicarbonate Currents and Synaptic Con-
version. When considering pharmacological interventions
for chloride-opathies, it is important to emphasize that a
number of anions can pass through ligand-gated chloride
channels, such as a GABA-A receptor or a glycine receptor
[6]. In the nervous system, chloride and bicarbonate ions
are the predominant current carriers. Thus, in a GABAergic
or glycinergic synapse, it is sometimes important to mathe-
matically delineate how much current is carried by chloride
ions versus bicarbonate ions. In normal conditions, chloride
ﬂuxes are usually signiﬁcantly larger than bicarbonate ﬂuxes
[6]. However, in situations where chloride gradients have
collapsed,thatis,CF ∼ = 0,theeﬀectsofbicarbonateionﬂuxes
on neuronal excitability become signiﬁcant [28, 42].
The chloride Nernst potential is an independent variable
from the bicarbonate Nernst potential. Thus, the sum of
the transmembrane chloride current and transmembrane
bicarbonate current can be represented by a transmembrane
anion current, deﬁned as:
Ianion = ICl + IHCO3 = GCl[Vm − ECl]+ GHCO3

Vm −EHCO3

,
(11)
Canion
F =
I∗
Cl + I∗
HCO3
Io
Cl + Io
HCO3
=
GCl

Δo
Cl + ΔV − Δ
μ
Cl

+

Δo
HCO3 + ΔV − Δ
μ
HCO3

GCl · Δo
Cl + GHCO3 · Δo
HCO3
.
(12)
For clarity, the driving potentials for Cl and HCO3 ions are
speciﬁcally identiﬁed with subscripts. Changes in the chlo-
ride and bicarbonate chemical potentials from norm-aver-
aged values are represented by:
Δ
μ
Cl = E
∗
Cl − Eo
Cl,
Δ
μ
HCO3 = E∗
HCO3 − Eo
HCO3.
(13)
In GABAergic and glycinergic synapses where the chloride
driving potential(i.e.,ΔCl)hasavalueclosetozero,theanion
channel Conversion Factor reduces to
Canion
F =
I
∗
Cl + I
∗
HCO3
Io
Cl + Io
HCO3
=
GHCO3

Δo
HCO3 + ΔV − Δ
μ
HCO3

GCl · Δo
Cl + GHCO3 · Δo
HCO3
.
(14)
In cases where ΔCl ∼ = 0a n dΔV = 0, GABAergic synapses
have a Conversion Factor approximated by:
Canion
F =
I
∗
HCO3
Io
Cl +Io
HCO3
=
GHCO3

Δo
HCO3 − Δ
μ
HCO3

GCl · Δo
Cl + GHCO3 · Δo
HCO3
. (15)
Note that the bicarbonate current remains referenced to the
chloride driving potential for normal conditions, as well as
the bicarbonate driving potential for normal conditions. Use
of ﬁxed reference points is appropriate for a mathematical
scaling factor. Deviations in bicarbonate driving potential
from norm-averaged conditions are accounted for by the
mathematical term, Δ
μ
HCO3.
In spinal nociceptive neurons, in which chloride gradi-
ents have collapsed (i.e., ΔCl ∼ = 0), outward ﬂux of HCO3
can produce signiﬁcant depolarizing currents, leading to the
generation of action potentials and pain. The magnitude of
these depolarized bicarbonate currents can be approximated
with the following equation:
I
∗
anion = Canion
F


Io
Cl + Io
HCO3

= Canion
F GHCO3 · Δo
HCO3. (16)
Modiﬁcations of the bicarbonate gradient will change the
magnitude of the Conversion Factor shown in (15).
3.4. Pharmacological Treatments for Chloride-opathies. Clin-
ical management of chloride-opathies diﬀers substantially
from the clinical management of channelopathies [6]. This
is because neuropharmaceuticals have traditionally been
designed to alter neuronal excitability through changes in
ionic conductance. Pharmacological agents can compensate
for the loss of chloride-dependent inhibitory tone by reduc-
ing overall neuronal excitability. However, they do not alter
the collapsed chloride gradient, the underlying cause of the
chloride-opathy.
Recently, anion transport inhibitors have been repur-
posed for the treatment of neuroexcitability disorders
linked to aberrant chloride homeostasis [42]. For example,
bumetanidehasbeenusedtotreatepilepsyinneonateinfants
[19]. By inhibiting inward chloride cotransport via NKCC1
(Figure 2), bumetanide partially restores the transmembrane
chloride gradient across postsynaptic membranes [6]. ThisPain Research and Treatment 9
occurs even though the activity of KCC2 remains deﬁcient,
and may explain the clinical beneﬁt of bumetanide in cases
of epilepsy where KCC2 transcription in cortical neurons,
or hippocampal neurons, is suspected to be abnormally low
[19].
An entirely new approach to treat chloride-opathies in
the CNS is to compensate for aberrant chloride-dependent
inhibitory tone by altering bicarbonate ﬂuxes through
GABA-A and glycine channels [42]. First, benzodiazepines
are used to open GABA-A channels. This treatment max-
imizes anion conductance through the postsynaptic mem-
brane. A carbonic anhydrase inhibitor (acetazolamide) is
also applied to suppress transmembrane bicarbonate ﬂuxes
by reducing intracellular bicarbonate formation [42]. The
outcome of applying the benzodiazepine, as well as the
carbonic anhydrase inhibitor, is a synergistic, antiallodynic
eﬀect. Decreased bicarbonate ﬂux reduces excitatory drive
through extrasynaptic GABA-A receptors. At the same time,
an augmented shunting inhibition through postsynaptic
GABA-A receptors is preserved [42]. The net result is a
suppression of pain generated at the spinal level.
For this particular situation, the generalized Conversion
Factor, Canion
F (see (14)), can be used to represent the
altered postsynaptic response of GABAergic and glycinergic
synapses in cells treated with carbonic anhydrase inhibitors.
Assuming transmembrane chloride gradients are completely
collapsed, (i.e., ΔCl = 0), transmembrane anion current is
represented by (16). The net current through the postsy-
naptic membrane is depolarizing because of the outward
bicarbonate ﬂux.
To considerthe action of potential pain therapeutics, it is
useful to consider the special case of when inward chloride
and outward bicarbonate currents exactly counteract each
other (i.e., Canion
F = 0). The bicarbonate gradient across the
postsynaptic cell membrane can be collapsed by the applica-
tion of a carbonic anhydrase inhibitor, acetazolamide, which
inhibits bicarbonate formation on both sides of the cell
membrane. As a result, the generalized anion Conversion
Factor can become nonzero (Figure 7). This restoration
of inhibitory tone is believed to correspond with the
antinociceptive action of acetazolamide [42].
Figure 7 illustrates the interplay between chloride and
bicarbonate driving potentials. In addition, the therapeutic
actions of bumetanide and acetazolamide are qualitatively
portrayed. Bumetanide moves the anion Conversion Factor
towardsa morepositivevalue,bypartially restoring anormal
transmembrane chloride gradient. Acetazolamide moves the
anion Conversion Factor toward a more positive value, by
reducing an outward (depolarizing) bicarbonate current.
When a residual inward chloride current is counterbalanced
by an outward bicarbonate current, the generalized anion
Conversion Factor is zero. An increase in the magnitude
of the anion Conversion Factor above zero indicates that
the synapse has become hyperpolarizing, thereby restoring
somechloride-dependentinhibitory toneto thepostsynaptic
neuron.
3.5. Chloride-opathies and Neuroinﬂammatory Disorders.
Widespreadevidencenowindicatesthatalargerangeofpain,
neurodegenerative, motor, and aﬀective disorders involve
neuroinﬂammatory processes mediated, in part, by activated
microglia [13, 43–45]. Activated microglia are associated
with Alzheimer’s Disease, Parkinson’s Disease, Huntington’s
Disease, multiple sclerosis, amyotrophic lateral sclerosis
(ALS), spasmodic dysphonia, and chronic neuropathic pain
disorders, including painful diabetic neuropathy [43–49].
Activated microglia have also been found in the brains of
autistic children [50], as well as individuals with schizophre-
nia [51].
In each of the above disorders, it is important to con-
sider how microglial-mediated chloride-opathies could
produce functional changes in neural circuits. Loss of
chloride-dependent inhibitory tone in speciﬁc spinal and/or
supraspinal sites could produce distinctive nociceptive,
autonomic, proprioceptive, and/or motor morbidities. For
example, downregulation of KCC2 in human cortical or
hippocampal neurons can lead to epileptic seizures [52,
53], whereas downregulation of KCC2 in spinal motor
neurons in an ALS rodent model leads to muscle weakness
[54]. Aberrant chloride cotransport is suspected to be an
etiological factor in schizophrenia [55]. Whether aberrant
chloride homeostasis arises from activated microglia [55],
which are present in the hippocampi of schizophrenic
patients [51], remains to be determined.
Downregulation of KCC2, and upregulation of NKCC1,
in the trigeminal subnucleus caudalis in rodents correlates
with the establishment of oral cavity neuropathic pain
following dentalpulpinﬂammation, inducedbylipopolysac-
charide [56]. KCC2 downregulation in these trigeminal
nociceptive neurons has been hypothesized to be mediated
by a BDNF-TrkB pathway, based upon the antinociceptive
actions of K252a, a TrkB antagonist. The presumed pain
transduction pathway in the brainstem [56] is thought to
parallel the well-characterized BDNF-TrkB-KCC2 pathway
that mediates microglial-mediated pain in the dorsal horn of
the spinal cord [3, 19].
From PET (positron emission tomography) imaging
studies, it is known that microglial activation can spread
from site-to-site through the neuraxis, presumably by
chemical signals conveyed by axonal transport [57]. This
type of remote neuroimmune activation [58] appears to
be involved in the establishment of neuroinﬂammation in
the thalamus, following peripheral nerve injury [57]. In
a PET imaging study of chronic pain patients, persistent
microglial activation was found in the thalamus, up to two
decades after the healing of a peripheral nerve injury [58]. In
rodents, sensitization of the thalamus can lead to widespread
allodynia throughout the body [59]. In addition, microglial
cell and astroglial cell activation in the rostroventromedial
medulla (RVM) has been correlated with hyperalgesia in a
rodent model of peripheral inﬂammation [60]. Thus, the
generation of neuropathic pain can become multi-focal,
involving glial cell activation in both spinal and supraspinal
sites. Althoughgliaactivationinsupraspinal centershasbeen
correlated with centralized neuropathic pain [57, 59, 60],
chloride-opathies in supraspinal sites have not yet been
causally connected with neuropathic pain.10 Pain Research and Treatment
At the cellular level, mathematical models of chloride-
opathies could be developed to describe: (a) inﬂux of chlo-
ride through chloride channels, (b) rate constants for diﬀer-
ent chloride cotransporters, (c) diﬀusive transport of chlo-
ride and bicarbonate within deﬁned cell volumes, and (d)
thebiochemicalandgeneticregulationofaniontransporters.
Mathematical models that have already been published
account for shifts in intracellular chloride concentration
resulting from the activation of GABA-A chloride channels
[61–63].
To date, the analysis of chloride-opathies in the CNS has
focused primarily on the upregulation and downregulation
of two chloride cotransporters, NKCC1, and KCC2. There
are, however, a number of other chloride cotransporters
in the CNS that contribute to overall intracellular chloride
homeostasis [64]. A comprehensive quantitative mathemati-
cal model of chloride-opathies, and their eﬀect on chloride-
dependent synaptic tone, will need to account for these
chloride cotransporters as well.
From imaging studies, is it known that transmembrane
chloride gradients are dynamic, and regionally diﬀerent
across the dimensions of individual neurons [65]. Sexual
dimorphism in the regulation and expression of chloride
cotransporters [66] might contribute to phenotypic diﬀer-
ences in the frequency of neuropathic pain between females
andmales.ThepromoteroftheKCC2bisoform,forinstance,
is regulated by upstream stimulating factor (USF) proteins,
which interact with many diﬀerent signaling cascades [65].
Genetic polymorphisms, tissue-speciﬁc isoform expression
patterns, as well as mutations of chloride cotransporters are
alsoknown[67–70].Alloftheabovefactors couldcontribute
to normal and pathological variations of the transmembrane
aniongradientacrosspostsynapticmembranes,whichisnow
recognized as a key integrative factor in the transduction of
pain.
4.Conclusions
In this paper, we have developed scaling factors to describe
the altered electrical behavior of chloride-dependent
synapses in conditions where chloride or bicarbonate ion
gradients are aberrant. These conversion factors predict the
behavior of the synapse in response to a change in chloride
and/orbicarbonateelectrochemical driving potentials.These
conversion factors can be used to describe synaptic behavior,
with or without, changes in the electrical driving potential,
ΔV, for these anions.
We have mathematically separated key system variables
for anion synaptic currents in our derivation of the general-
ized Conversion Factor. This mathematical approach allows
the contributions of chloride gradients (i.e., Δ
μ
Cl)a n db i c a r -
bonate gradients (i.e., Δ
μ
HCO3) to be independently discerned
from changes in resting membrane potential (i.e., ΔV). In
this regard, the mathematical and symbolic representations
of synaptic conversion, which we have developed in this
paper, help parameterize and illustrate the critical roles
that anion electrochemical driving potentials play in the
transduction of pain.
Because transmembrane chloride gradients in noci-
ceptive projection neurons are linked to the actions of
neighboring activated microglia, the generalized Conversion
Factor, Canion
F , can be viewed as a system parameter that
describes the action of their GABAergic and glycinergic
tetrapartite synapses, that is, anion-dependent neuronal
synapses whose functions are modiﬁed by neighboring glia.
Fromthestandpointofsynaptictone, Canion
F isameasure ofa
postsynaptic neuron’sresponsetoGABAergicandglycinergic
input. Functional roles of chloride-opathies (i.e., pathologi-
cal chloride driving potentials) in the genesis of neuropathic
pain can be deﬁned, and quantiﬁed, using this parameter.
Symbolic representations of synaptic conversion (Figure 4)
can be used to illustrate how aberrant anion homeostasis
disrupts the integrative logic of spinal nociceptive circuits
(Figures 5 and 6).
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